does tirzepatide have exendin 4 Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology Amino acid sequence alignment of

Hao Y, Zhu YJ, Zou S, Zhou P, Hu YW, Zhao QX, et al

A couple of margaritas add 800 to 1000 calories

All of these oral medications have similar side effects, mainly GI-related discomforts such as nausea, constipation, diarrhea, or heartburn

doi: 10.1097/MIB.0000000000000847 95 KellerJBinnewiesURschMJuul HolstJBeglingerCAndresenVet al

The primary mechanisms of action include: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood glucose levels without causing excessive hypoglycaemia Suppressing glucagon release from pancreatic alpha cells, reducing hepatic glucose production Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake Most GLP-1 receptor agonists are administered via subcutaneous injection, with dosing frequencies ranging from once daily to once weekly depending on the specific formulation